{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:40:34Z","timestamp":1787060434924,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/2021\/SKK08\/UKM\/03\/1"],"award-info":[{"award-number":["FRGS\/2021\/SKK08\/UKM\/03\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2021\/SKK08\/UKM\/03\/1"],"award-info":[{"award-number":["FRGS\/1\/2021\/SKK08\/UKM\/03\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jpba.2024.116243","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T11:49:15Z","timestamp":1716810555000},"page":"116243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Improved HPLC method with automated pre-column sample derivatisation for serum pegylated L-asparaginase activity measurement in paediatric acute lymphoblastic leukaemia patients"],"prefix":"10.1016","volume":"247","author":[{"given":"Yan Qi","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C-Khai","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamin","family":"Mohd Saffian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Makpol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jpba.2024.116243_bib1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1080\/10428194.2017.1386305","article-title":"Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia","volume":"59","author":"Salzer","year":"2018","journal-title":"Leuk. Lymphoma"},{"issue":"9","key":"10.1016\/j.jpba.2024.116243_bib2","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1200\/JCO.1993.11.9.1780","article-title":"Comparative pharmacokinetic studies of three asparaginase preparations","volume":"11","author":"Asselin","year":"1993","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.jpba.2024.116243_bib3","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1200\/JCO.18.02439","article-title":"Antibodies predict pegaspargase allergic reactions and failure of rechallenge","volume":"37","author":"Liu","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jpba.2024.116243_bib4","article-title":"Current use of asparaginase in acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"10","author":"Maese","year":"2022","journal-title":"Front Pedia"},{"issue":"5","key":"10.1016\/j.jpba.2024.116243_bib5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/10428190701292049","article-title":"The anti-asparagines antibodies correlate with L-asparagines activity and may affect clinical outcome of childhood acute lymphoblastic leukemia","volume":"48","author":"Zalewska-Szewczyk","year":"2007","journal-title":"Leuk. Lymphoma"},{"issue":"10","key":"10.1016\/j.jpba.2024.116243_bib6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2217\/fon-2021-1288","article-title":"Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences","volume":"18","author":"Burke","year":"2022","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.jpba.2024.116243_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3324\/haematol.2015.137380","article-title":"Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation","volume":"101","author":"van der Sluis","year":"2016","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.jpba.2024.116243_bib8","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1080\/10428194.2018.1542146","article-title":"Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children's Oncology Group AALL07P4","volume":"60","author":"Schore","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"9","key":"10.1016\/j.jpba.2024.116243_bib9","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0959-8049(96)00131-1","article-title":"Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations","volume":"32","author":"Boos","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.jpba.2024.116243_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0003-2697(74)90284-X","article-title":"A simple and rapid method for the estimation of L-asparaginase in chromatographic and electrophoretic effluents: comparison with other methods","volume":"59","author":"Jayaram","year":"1974","journal-title":"Anal. Biochem."},{"issue":"7","key":"10.1016\/j.jpba.2024.116243_bib11","first-page":"478","article-title":"High-throughput asparaginase activity assay in serum of children with leukemia","volume":"6","author":"Fernandez","year":"2013","journal-title":"Int J. Clin. Exp. Med."},{"issue":"34","key":"10.1016\/j.jpba.2024.116243_bib12","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1200\/JCO.2014.55.5763","article-title":"Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4","volume":"32","author":"Angiolillo","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jpba.2024.116243_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0003-2697(02)00232-4","article-title":"Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum","volume":"309","author":"Lanvers","year":"2002","journal-title":"Anal. Biochem."},{"issue":"6","key":"10.1016\/j.jpba.2024.116243_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/bcp.14216","article-title":"A comparison of asparaginase activity in generic formulations of E.coli derived L-asparaginase: in-vitro study and retrospective analysis of asparaginase monitoring in pediatric patients with leukemia","volume":"86","author":"Sankaran","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.jpba.2024.116243_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/diagnostics14060623","article-title":"Determination of l-asparaginase activity and its therapeutic monitoring in children with hematological malignancies in a single Croatian center","volume":"14","author":"Krleza","year":"2024","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.jpba.2024.116243_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/bmc.1096","article-title":"An isocratic fluorescence HPLC assay for the monitoring of L-asparaginase activity and L-asparagine depletion in children receiving E. coli L-asparaginase for the treatment of acute lymphoblastic leukaemia","volume":"23","author":"Nath","year":"2009","journal-title":"Biomed. Chromatogr."},{"issue":"3","key":"10.1016\/j.jpba.2024.116243_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.12793\/tcp.2018.26.3.134","article-title":"Development of a UPLC-MS\/MS method for the therapeutic monitoring of L-asparaginase","volume":"26","author":"Jeong","year":"2018","journal-title":"Transl. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.jpba.2024.116243_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/FTD.0000000000000472","article-title":"Therapeutic drug monitoring of asparaginase activity-method comparison of MAAT and AHA test used in the International AIEOP-BFM ALL 2009 Trial","volume":"40","author":"Lanvers-Kaminsky","year":"2018","journal-title":"Ther. Drug Monit."},{"issue":"7","key":"10.1016\/j.jpba.2024.116243_bib19","article-title":"Our experiences with asparaginase activity measurements in children with lymphoblastic diseases","volume":"10","author":"M\u00fcller","year":"2023","journal-title":"Children (Basel)"},{"issue":"27","key":"10.1016\/j.jpba.2024.116243_bib20","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.1007\/s00216-018-1326-x","article-title":"A critical analysis of L-asparaginase activity quantification methods-colorimetric methods versus high-performance liquid chromatography","volume":"410","author":"Magri","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.jpba.2024.116243_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0021-9673(98)01088-7","article-title":"Stability and characteristics of the o-phthaldialdehyde\/3-mercaptopropionic acid and o-phthaldialdehyde\/N-acetyl-l-cysteine reagents and their amino acid derivatives measured by high-performance liquid chromatography","volume":"835","author":"Moln\u00e1r-Perl","year":"1999","journal-title":"J. Chromatogr. A"},{"issue":"9","key":"10.1016\/j.jpba.2024.116243_bib22","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/chromsci\/bmy053","article-title":"Optimization of a precolumn OPA derivatization HPLC assay for monitoring of L-asparagine depletion in serum during L-asparaginase therapy","volume":"56","author":"Zhang","year":"2018","journal-title":"J. Chromatogr. Sci."},{"issue":"5","key":"10.1016\/j.jpba.2024.116243_bib23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/etc.147","article-title":"Comparing weighted and unweighted analyses applied to data with a mix of pooled and individual observations","volume":"29","author":"Anderson","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.jpba.2024.116243_bib24","article-title":"Green profile tools: current status and future perspectives","volume":"6","author":"Locatelli","year":"2023","journal-title":"Adv. Sample Prep."},{"key":"10.1016\/j.jpba.2024.116243_bib25","series-title":"Optimization in HPLC: concepts and strategies","first-page":"73","article-title":"Optimization strategies in HPLC for the separation of biomolecules","author":"Strasser","year":"2021"},{"issue":"1","key":"10.1016\/j.jpba.2024.116243_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02491841","article-title":"Influence of column characteristics on retention and selectivity in RP-HPLC","volume":"54","author":"Szepesy","year":"2001","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2024.116243_bib27","series-title":"Ultra-high performance liquid chromatography and its applications","first-page":"31","article-title":"Method transfer between HPLC and UHPLC platforms","author":"Webster","year":"2013"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524002838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524002838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:06:22Z","timestamp":1778547982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524002838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":27,"alternative-id":["S0731708524002838"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116243","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved HPLC method with automated pre-column sample derivatisation for serum pegylated L-asparaginase activity measurement in paediatric acute lymphoblastic leukaemia patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116243"}}